Records containing: Multiple Sclerosis, Relapsing-Remitting
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-10-12RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. A Randomized Phase 3 Study Comparing Rituximab With Dimethyl Fumarate in Early Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome.
-
CLINICAL_TRIALS study record update · 2021-09-08An International Multicenter Double-blind Placebo-controlled Randomized Study to Compare the Efficacy, Safety and Tolerability of BCD-054 (JSC BIOCAD, Russia), 180 μg and 240 μg, Versus Avonex® (Biogen Idec Ltd., UK) in Patients With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-09-05The Effect of Tecfidera® (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events.
-
CLINICAL_TRIALS study record update · 2021-08-30Longitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients: A Single-Blind Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-08-24A Non-interventional Observation Study to Evaluate Immune Responses Following Seasonal Influenza Vaccine in Participants With Relapsing Multiple Sclerosis Treated With Cladribine Tablets
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-08-10Sensitivity of Quantitative Motor Performance Measures in Multiple Sclerosis - a Prospective Cohort Study Over Two Years Using Microsoft Kinect
-
CLINICAL_TRIALS study record update · 2021-07-29ClinicalTrials.gov study NCT01417312
-
CLINICAL_TRIALS study record update · 2021-07-22The Impact of a Planned 12-week Dosing Interruption of Natalizumab on Immune Cell Trafficking, Pharmacokinetic (PK)/Pharmacodynamic (PD) Parameters, and Multiple Sclerosis (MS) Disease Stability.
-
CLINICAL_TRIALS study record update · 2021-07-15A Phase II Randomized, Double-Blind, Parallel-Group, Placebo Controlled Crossover Trial to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-06-03A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of Acthar® in Subjects With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-05-18Study by Magnetic Resonance Imaging of the Modifications of the Vasoreactivity and Cerebral Connectivity in the Progressive Forms of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-04-19RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS. A Randomized Trial of Long-term Dosage of Rituximab in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-04-08Cortical Lesions in the Primary Sensorimotor Hand Area and Their Impact on Dexterity in Multiple Sclerosis: a 7T MRI Study
-
CLINICAL_TRIALS study record update · 2021-04-06The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial
-
CLINICAL_TRIALS study record update · 2021-03-24Association of Possible Biomarkers With Disease Activity in Patients Treated With Teriflunomide (Aubagio)
-
CLINICAL_TRIALS study record update · 2021-03-03Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-02-26Effect of Photobiomodulation Therapy on Muscle Function and Inflammation in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-02-23Effect of CoDuSe Balance Training and Step Square Exercises on Risk of Fall in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-02-03An Open-Label Study To Evaluate the Efficacy and Safety of Ocrelizumab in Patients With Relapsing Multiple Sclerosis Who Have A Suboptimal Response to an Adequate Course of Disease-Modifying Treatment
-
CLINICAL_TRIALS study record update · 2021-01-11Maximizing Outcome of Multiple Sclerosis Transplantation: "MOST" Trial
-
CLINICAL_TRIALS study record update · 2020-11-24A Randomized, Single Blind, Placebo-controlled, Single Ascending Dose/Repeat Dose Cohort Study to Assess Safety, Tolerability, Pharmacokinetics and Immunogenicity of GSK1223249 in Patients With Relapsing Forms of Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2020-11-12Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis - Assessment of Mechanism of Action
-
CLINICAL_TRIALS study record update · 2020-10-20An International, Double-blind, Randomised, Placebo-controlled Phase IIb Trial to Assess the Efficacy, Safety, and Pharmacokinetics of GNbAC1 in Patients With Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-10-20A Long-Term International, Extension of Study GNC-003 With GNbAC1 in Patients With Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2020-10-19The Safety and Cost-effectiveness of Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS): a Randomized Rater-blinded Multicenter Trial.